These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 68989)

  • 1. Human histocompatibility determinants and virus antigens: effect of measles virus infection on HLA expression.
    Haspel MV; Pellegrino MA; Lampert PW; Oldstone MB
    J Exp Med; 1977 Jul; 146(1):146-56. PubMed ID: 68989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of the major histocompatibility complex and viral antigens on the plasma membrane of a measles virus-infected cell.
    Oldstone MB; Fujinami RS; Tishon A; Finney D; Powell HC; Lampert PW
    Virology; 1983 Jun; 127(2):426-37. PubMed ID: 6575495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes.
    Perrin LH; Tishon A; Oldstone MB
    J Immunol; 1977 Jan; 118(1):282-90. PubMed ID: 830751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens.
    Jacobson S; Richert JR; Biddison WE; Satinsky A; Hartzman RJ; McFarland HF
    J Immunol; 1984 Aug; 133(2):754-7. PubMed ID: 6203977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of H-2 antigens following acute measles virus infection.
    Rager-Zisman B; Ju G; Rajan TV; Bloom BR
    Cell Immunol; 1981 Apr; 59(2):319-29. PubMed ID: 6169444
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulation.
    Joseph BS; Oldstone MB
    J Exp Med; 1975 Oct; 142(4):864-76. PubMed ID: 1176889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4⁺ T cells but are incapable of cross-presentation.
    van der Vlist M; de Witte L; de Vries RD; Litjens M; de Jong MA; Fluitsma D; de Swart RL; Geijtenbeek TB
    Eur J Immunol; 2011 Sep; 41(9):2619-31. PubMed ID: 21739428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic injury in measles virus infection. IV. Antigens modulation and abrogation oflymphocyte lysis of virus-infected cells.
    Oldstone MB; Tishon A
    Clin Immunol Immunopathol; 1978 Jan; 9(1):55-62. PubMed ID: 618410
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of class I and class II transplantation antigens in rat brain during fatal and non-fatal measles virus infection.
    Olsson T; Maehlen J; Löve A; Klareskog L; Norrby E; Kristensson K
    J Neuroimmunol; 1987 Oct; 16(2):215-24. PubMed ID: 3497946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune reactive measles virus polypeptides on the cell's surface: turnover and relationship of the glycoproteins to each other and to HLA determinants.
    Fujinami RS; Sissons JG; Oldstone MB
    J Immunol; 1981 Sep; 127(3):935-40. PubMed ID: 6167634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of cytolytic T-cell cultures displaying measles virus specificity and human histocompatibility leukocyte antigen restriction.
    Sethi KK; Stroehmann I; Brandis H
    Infect Immun; 1982 May; 36(2):657-61. PubMed ID: 6282755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological mechanisms controlling measles virus infection.
    Cernescu C
    Virologie; 1981; 32(1):41-55. PubMed ID: 6171091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-induced capping of measles virus antigens on plasma membrane studied by electron microscopy.
    Lampert PW; Joseph BS; Oldstone MB
    J Virol; 1975 May; 15(5):1248-55. PubMed ID: 49437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of measles virus from silently infected human lymphocytes.
    Lucas CJ; Ubels-Postma JC; Rezee A; Galama JM
    J Exp Med; 1978 Oct; 148(4):940-52. PubMed ID: 702064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of HLA-DRB1-bound self-peptides following measles virus infection.
    Ovsyannikova IG; Johnson KL; Naylor S; Poland GA
    J Immunol Methods; 2005 Feb; 297(1-2):153-67. PubMed ID: 15777939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane and cytoplasmic changes in virus-infected cells induced by interactions of antiviral antibody with surface viral antigen.
    Oldstone MB; Fujinami RS; Lampert PW
    Prog Med Virol; 1980; 26():45-93. PubMed ID: 6158744
    [No Abstract]   [Full Text] [Related]  

  • 17. Mixed lymphocyte culture determinants, measles infection and multiple sclerosis.
    Platz P; Dupont B; Fog T; Ryder L; Thomsen M; Svejgaard A; Jersild C
    Proc R Soc Med; 1974 Nov; 67(11):1133-6. PubMed ID: 4140520
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line.
    Ehrnst AC
    J Immunol; 1975 Mar; 114(3):1077-82. PubMed ID: 1089724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histocompatibility types and measles antibodies in multiple sclerosis.
    Fewster ME; Myers LW; Ellison GW; Walford RL
    J Neurol Sci; 1977 Nov; 34(2):287-96. PubMed ID: 925715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles virus infection of unstimulated blood mononuclear cells in vitro: antigen expression and virus production preferentially in monocytes.
    Salonen R; Ilonen J; Salmi A
    Clin Exp Immunol; 1988 Feb; 71(2):224-8. PubMed ID: 3280184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.